The direct answer: no mainstream smartwatch gives you a real blood pressure number the way a doctor’s cuff does — except one. Apple Watch Series 11 only sends a passive notification if it detects hypertension-like patterns over time; it never shows a systolic/diastolic reading. Samsung’s Galaxy Watch does show an actual number, but it’s an uncleared “wellness feature” that needs monthly recalibration against a real cuff to stay meaningful. Omron’s HeartGuide is the outlier: it’s a true inflatable cuff built into a watch band, and it’s the only one of the three that’s FDA-cleared as an actual blood pressure monitor.
At a Glance: What Each Device Actually Does
- Best for early-warning screening: Apple Watch Series 11 — flags a hypertension pattern passively, doesn’t show a number, no calibration hassle.
- Best for a rough daily trend: Samsung Galaxy Watch — shows real systolic/diastolic numbers, but needs a cuff to recalibrate every 28 days and isn’t FDA-cleared.
- Best for an actual clinical-grade reading: Omron HeartGuide — a real oscillometric cuff on your wrist, FDA-cleared since 2019, at a real cost.
Why “Blood Pressure Monitoring” Means Three Different Things Here
Wrist-worn blood pressure claims fall into two completely different technology categories, and mixing them up is where most of the confusion online comes from. The first is optical — a light-based (PPG) sensor watches how your blood vessels respond to each heartbeat and estimates pressure or flags a pattern from that. The second is oscillometric — an actual miniature air cuff inflates against your wrist and measures pressure mechanically, the same physical principle as the cuff at your doctor’s office. Only one device in this comparison uses the second method.
That distinction matters because the FDA regulates the two very differently. A device that displays an actual number and is marketed for managing a diagnosed condition typically needs clearance as a medical device. A feature that only flags a general pattern for you to discuss with a doctor — never displaying a number — can qualify for a lighter review pathway, or in some cases none at all if it’s framed purely as “wellness.” That’s exactly the fork in the road between our three devices.
Apple Watch Series 11: Hypertension Notifications, Not a Blood Pressure Number
Apple’s hypertension notification feature, introduced with Apple Watch Series 11 and watchOS 26, works entirely in the background. According to Apple’s own September 2025 announcement, the feature “uses data from the optical heart sensor to analyze how a user’s blood vessels respond to the beats of the heart,” reviewing that data passively over rolling 30-day periods. If the algorithm sees a consistent pattern associated with chronic high blood pressure, it sends a notification — that’s the entire output. There is no systolic or diastolic number anywhere in the experience.
The feature received FDA clearance in September 2025 and is available on Apple Watch Series 9 and later, plus Apple Watch Ultra 2 and later, running watchOS 26 — it isn’t exclusive to the newest Series 11 hardware, though Apple launched it alongside that model. Apple’s own guidance for anyone who gets a notification is to log blood pressure with a separate cuff for seven days and share those readings with a doctor, which underscores that the watch is a screening trigger, not a diagnostic tool. Apple Watch Series 11 (GPS, 42mm) starts at $399 at retail, though it’s been discounted to around $299 repeatedly through 2026, according to retailer listings.
Samsung Galaxy Watch: Real Numbers, But Not FDA-Cleared
Samsung takes the opposite approach: its Blood Pressure Monitoring feature, built into the Samsung Health Monitor app, displays an actual systolic and diastolic reading plus heart rate, using the watch’s optical sensors and a pulse-wave-analysis algorithm. It’s compatible with Galaxy Watch4 and later running Wear OS 4.0 or newer, and Samsung began a phased US rollout of the feature on April 6, 2026, after years of the feature being US-restricted.
The catch is regulatory, not technical: Samsung has been explicit that the feature “doesn’t require FDA clearance” because it’s classified as a wellness feature rather than a medical device, and the company’s own guidance says not to treat it as “an alternative to a medical-grade blood pressure monitor.” On top of that, the watch needs to be recalibrated against a real blood pressure cuff roughly every 28 days to stay accurate — skip that, and Samsung’s own documentation says the readings drift. Galaxy Watch8 (40mm, Wi-Fi/Bluetooth) starts at $299.99 directly from Samsung, and most of that price range from Watch4 onward supports the feature.
Omron HeartGuide: The Only Real FDA-Cleared Wrist Blood Pressure Monitor
Omron’s HeartGuide is a fundamentally different product category wearing a smartwatch’s clothing. Instead of estimating pressure from light and an algorithm, it uses a miniature oscillometric pump built into the watch band — the same mechanism as a standard clinical cuff — to physically inflate against your wrist and take a real measurement. Omron received 510(k) FDA clearance for the HeartGuide on January 8, 2019, and it remains, as far as we can verify, the only wrist-worn device on the market with that specific clearance for actual blood pressure measurement rather than a wellness estimate or a notification.
That accuracy comes with real tradeoffs. The inflation cycle takes roughly 30 seconds and feels like a scaled-down version of a normal cuff reading — noticeably different from the instant, passive readings of the other two watches. It’s also the most expensive device here by a wide margin at $499 direct from Omron Healthcare, and its smartwatch features (notifications, step tracking) are secondary to its core job as a legitimate medical device you wear.
What Each Device Actually Gives You — and What It Costs
This is the comparison that doesn’t exist anywhere else: lining up what you actually get, not just what the marketing implies, against the real price and ongoing effort required.
| Device | Shows an Actual BP Number? | FDA Status | Ongoing Effort | Price |
|---|---|---|---|---|
| Apple Watch Series 11 | No — notification only, no systolic/diastolic display | FDA-cleared (hypertension notification, Sept. 2025) | None — passive background monitoring | From $399 ($299 on frequent sales) |
| Samsung Galaxy Watch (Watch4+) | Yes — full systolic/diastolic reading | Not FDA-cleared — self-classified as a wellness feature | Recalibrate against a real cuff every ~28 days | From $299.99 (Galaxy Watch8) |
| Omron HeartGuide | Yes — true oscillometric measurement | FDA 510(k)-cleared (Jan. 8, 2019) | None beyond normal cuff-style use | $499 |
Prices reflect current manufacturer and retailer listings as of publication and change frequently.
So Which One Should You Actually Trust?
If you just want an early warning that something might be off, without buying a new device solely for it, the Apple Watch’s notification feature is the lowest-friction option — it works passively on hardware many people already own, and its entire job is to tell you when to go get a real reading elsewhere. It’s a smoke detector, not a thermometer, and that’s a legitimate, FDA-cleared use case on its own terms.
If you have already-diagnosed hypertension and want to log daily trends for a doctor without a separate cuff every time, the Galaxy Watch is the middle path — but go in accepting that “not FDA-cleared” is a real limitation, not a technicality, and that skipping the 28-day recalibration undermines the entire feature. It’s a trend tool, not a diagnostic one.
If you actually need a number you and a doctor can rely on — because you’re titrating medication, managing a diagnosed condition closely, or your doctor has specifically asked for home readings — the Omron HeartGuide is the only device here built and cleared for that job. It costs more and takes longer per reading because it’s doing something fundamentally more rigorous than the other two.
How We Compared
PicksWeTrust did not physically test these three devices against a clinical reference cuff for this comparison. Our conclusions here are built from each manufacturer’s own published specifications, FDA clearance documentation and announcements, and reporting from outlets that have covered each feature’s rollout and regulatory status, cross-referenced against each other rather than relying on any single source. Where we cite a price or clearance date, we verified it directly against the manufacturer’s current listing or the relevant FDA filing. You can read more about our process on our editorial standards page. Prices are approximate, current as of publication, and change frequently — confirm the latest price with the retailer before buying.
Blood Pressure Smartwatches: FAQ
Can any smartwatch actually measure blood pressure like a doctor’s cuff?
Not in the traditional sense, with one narrow exception. Omron’s HeartGuide uses a true inflatable oscillometric cuff built into the band and is FDA-cleared for actual blood pressure measurement. Apple Watch and Samsung Galaxy Watch both use optical sensors instead — Apple’s only sends a hypertension notification with no number, and Samsung’s shows a number but isn’t FDA-cleared and needs monthly cuff recalibration.
Is the Apple Watch hypertension feature the same as a blood pressure reading?
No. Apple’s feature only sends a notification if it detects a pattern consistent with chronic hypertension over a rolling 30-day window — it never displays a systolic or diastolic number. Apple’s own guidance is to confirm any alert with a real blood pressure cuff over the following week and share those readings with a doctor.
Is Samsung’s Galaxy Watch blood pressure feature FDA-approved?
No. Samsung has said the feature doesn’t require FDA clearance because it’s classified as a wellness feature rather than a medical device, and the company explicitly advises against treating it as a substitute for a medical-grade blood pressure monitor.
Why does the Galaxy Watch need to be recalibrated with a cuff?
Because it estimates blood pressure from optical pulse-wave data rather than measuring it directly, its accuracy drifts over time as your baseline vascular signals change. Samsung requires recalibrating against a traditional cuff roughly every 28 days to keep the estimate meaningful.
Is the Omron HeartGuide worth the extra cost over a smartwatch?
If you need a genuinely reliable blood pressure number — for managing diagnosed hypertension, adjusting medication under a doctor’s guidance, or tracking readings a physician will actually rely on — yes, because it’s the only device here actually cleared and built for that job. If you just want a general early-warning signal, a smartwatch’s notification feature may be enough.
Do any of these devices replace regular doctor visits for blood pressure?
No. All three manufacturers frame their features as screening or trend tools meant to prompt a conversation with a healthcare provider, not to replace clinical monitoring or diagnosis. Talk to a doctor about how to interpret any reading or notification from a consumer wearable.
Curious how other health wearables stack up? Our comparison of Abbott Lingo vs. Dexcom Stelo vs. Signos glucose monitors covers a similar accuracy-vs-convenience tradeoff for at-home health tracking, and our smart scales vs. body composition monitors comparison looks at another wrist-adjacent health metric worth double-checking before you trust it. For more wearable comparisons like this one, browse our full Wearable Tech category.
